Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation Controversies and Advances 2019

Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

Presenter: Roxana Mehran

November 15, 2019

Presentation TCT 2019

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Presenter: Yoshinobu Onuma

September 27, 2019

Presentation TCT 2019

Insights From GLOBAL LEADERS and GLASSY

Presenter: Pascal Vranckx

September 26, 2019

Presentation CIT 2019

Global Leaders and Glassy

Presenter: Patrick W. Serruys

March 28, 2019

Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation. Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presentation ACC 2019

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

Presenter: Marco Valgimigli

March 18, 2019

Presentation TCT 2018

GLOBAL LEADERS: First Report of the Results in ACS and Non-ACS Subgroups

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Pascal Vranckx

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys

September 24, 2018

Presentation TCT 2018

ESC 2018 Late Breaking Trial #1 Global Leaders: What I Liked and What I Question

Presenter: Deepak L. Bhatt, Gregg W. Stone, Giuseppe Biondi-Zoccai

September 23, 2018

Presentation TCT 2018

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Patrick W. Serruys

September 23, 2018

Presentation TCT 2018

TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial

Presenter: George D. Dangas, Germano Di Sciascio, Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

TCT-118: The Impact of Bifurcation Stenting Techniques on the Clinical Events: the Stratified Analysis of 2,510 Bifurcated Lesions According to MADS Classification in the Global LEADERS Trial

Presenter: Michael A. Kutcher, Tullio Palmerini, Norihiro Kogame

September 21, 2018

Presentation TCT 2017

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates

October 30, 2017

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2015

From WOEST, DAPT, and PEGASUS to GLOBAL LEADERS and TWILIGHT: What Answers Can We Expect (and Not Expect) From GLOBAL LEADERS and TWILIGHT?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Roxana Mehran

October 11, 2015

Presentation TCT 2013

Design and Rationale of GLOBAL LEADERS

Presenter: Stephan Windecker

October 28, 2013

Advertisement

Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Insights From GLOBAL LEADERS and GLASSY

Global Leaders and Glassy

Primary Results of the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

GLOBAL LEADERS: First Report of the Results in ACS and Non-ACS Subgroups

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

ESC 2018 Late Breaking Trial #1 Global Leaders: What I Liked and What I Question

GLOBAL LEADERS in Perspective: Perspectives on Ticagrelor Monotherapy

TCT-112: Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Event in the Global Leaders Trial

TCT-118: The Impact of Bifurcation Stenting Techniques on the Clinical Events: the Stratified Analysis of 2,510 Bifurcated Lesions According to MADS Classification in the Global LEADERS Trial

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

From WOEST, DAPT, and PEGASUS to GLOBAL LEADERS and TWILIGHT: What Answers Can We Expect (and Not Expect) From GLOBAL LEADERS and TWILIGHT?

Design and Rationale of GLOBAL LEADERS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content